all institutions in the country have been banned from carrying out clinical trials on a new drug without the permission from the Drugs Controller General of India (dcgi). This directive was issued by the government recently. It will cover both clinical investigations and clinical experiments. Trials, including those of private research organisations, are now under government control. The regulation aims to streamline and expedite approval procedures for the manufacture and import of new drugs. If an applicant fails to meet the conditions of approval, under the amended rules his permission can be revoked or suspended. The amendment also prescribes forms and approvals for making applications to get nod for trial of a new drug to the dcgi.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.